Compare SUPN & QS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | QS |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.8B |
| IPO Year | 2010 | 2020 |
| Metric | SUPN | QS |
|---|---|---|
| Price | $42.63 | $4.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 9 |
| Target Price | ★ $61.75 | $6.66 |
| AVG Volume (30 Days) | 566.5K | ★ 9.9M |
| Earning Date | 11-03-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.15 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $392,755,000.00 | N/A |
| Revenue This Year | $23.21 | N/A |
| Revenue Next Year | $54.85 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $40.51 | $4.46 |
| 52 Week High | $59.68 | $19.07 |
| Indicator | SUPN | QS |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 34.26 |
| Support Level | $42.54 | N/A |
| Resistance Level | $52.33 | $5.34 |
| Average True Range (ATR) | 1.40 | 0.20 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 44.81 | 21.73 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional nodes. The company operates in one operating segment only.